Page URL:

First IVF baby born after new technique to eliminate genetic disease

13 April 2015
Appeared in BioNews 797

The first baby in Europe has been born following a new IVF-based technique developed to prevent the inheritance of genetic disease.

The screening technique, called karyomapping, is a type of PGD (preimplantation genetic diagnosis) procedure. Current PGD methods are developed on a case-by-case basis to test embryos for the presence of a specific mutation found in one or both of the parents' DNA and can involve months of laboratory work.

Karyomapping, on the other hand, can test for the same diseases, but can be completed much faster and is no more expensive than traditional PGD methods. It can also be used to check that embryos have the correct number of chromosomes.

Mrs Carmen Meagu suffers from Charcot-Marie-Tooth disease, a group of rare disorders of the peripheral nervous system that cause muscle degeneration and sensation loss in the feet and hands. She inherited the disease from her father, and had a 50 percent chance of passing it on to her children.

Speaking to The Telegraph, Mrs Meagu said: 'For me the risk was too high. I was told I could try and get pregnant and have a test at 16 weeks, but that really wasn't an option for me because it would have been too hard to have an abortion at that stage.

'Then we were told about a clinic in London which could screen the disease out, and we felt we had to try'.

The technique involves using DNA from Mrs Meagu, her husband Gabriel, and another family member, to compare roughly 300,000 different points across the genome called SNPs (single nucleotide polymorphisms). This allows scientists to find characteristic features that are unique to the chromosome carrying the defective gene. Following a standard IVF cycle, embryos are biopsied to find out which ones are free of the genetic disease.

Mr Paul Serhal is the founder and medical director of the Centre for Reproductive and Genetic Health, where the technique was used in December 2013. Also speaking to The Telegraph, he explained: 'Essentially, karyomapping finds a fingerprint that is unique to the chromosome that carries the defective gene.

'It is then possible to test embryos produced using IVF for this presence of this fingerprint. Whenever the fingerprint is seen in an embryo it means that it has inherited the chromosome carrying the defective gene. The test checked for Charcot Marie Tooth disease and at the same time for chromosomal abnormalities, such as Down's syndrome, enabling us to avoid inadvertently transferring an embryo which may otherwise not have been viable.'

Mr and Mrs Meagu's son Lucas was born in December 2014. Mrs Meagu said: 'I obviously worry, like all mothers, but now I worry about normal things. I know for sure that he is not only free of Charcot-Marie-Tooth disease but also other illnesses. I would recommend it to any other mother who is worried about passing on an illness.'

Karyomapping was developed by a team led by Professor Darren Griffin at the University of Kent, in collaboration with researchers at Illumina. It is now available on the NHS for genetic diseases that are licensed by the Human Fertilisation and Embryology Authority.

First baby born clear of genetic illnesses after IVF – doing well
Digital Journal |  30 March 2015
First baby born from IVF technique which eliminates inherited disease
The Telegraph |  28 March 2015
First IVF baby born from Karyomapping technique
The Centre for Reproductive and Genetic Health (press release) |  2 April 2015
New IVF Genetic Screening Technique Allows Babies At Risk For Inherited Illnesses To Be Born Disease Free
Muscular Dystrophy News |  8 April 2015
4 September 2017 - by Anna Leida 
A new imaging technique can help assess the quality of early-stage embryos...
9 May 2016 - by James Brooks 
The UK's first baby resulting from an embryo that was screened using next-generation DNA sequencing has been born in Oxford...
26 October 2015 - by Jessica Richardson 
A test which measures mitochondrial DNA levels in the embryo could help increase IVF success rates, scientists claim...
21 September 2015 - by Dr Mary Yarwood 
The Human Fertilisation and Embryology Authority has released its second annual report into adverse incidents at fertility clinics in the UK, showing a slight reduction in the overall number of reported problems following fertility treatment...
6 July 2015 - by Kirsty Oswald 
In a national referendum, a majority of Swiss voters have supported allowing preimplantation genetic diagnosis to screen for genetic diseases...
9 July 2012 - by Dr Lux Fatimathas 
US researchers have for the first time sequenced the genome of a fetus using only a blood sample from the mother. It is hoped this new form of non-invasive sampling could allow doctors to screen for a range of genetic diseases prenatally, with minimal risk to the fetus...
9 May 2011 - by Dr Ainsley Newson 
As highlighted in BioNews, in early April 2011 the UK's Human Genetics Commission (HGC) published a report supporting preconception genetic testing and screening (1). Preconception screening, which can be broadly described as identifying carriers of genetic mutations to inform reproductive decision-making for the person tested or his/her relatives, is well established in some jurisdictions but relatively unknown in the UK...
30 November 2009 - by Rosie Beauchamp 
On Wednesday 18th November 2009 a Progress Educational Trust (PET) conference - 'Does Genetics Matter? Help Hype and the New Horizon of Epigenetics' - was held at Clifford Chance in Canary Wharf. The initial session of the day was called 'Families with Monogenetic Disease' and was chaired by Dr Christine Patch, Chair of the British Society for Human Genetics and Consultant Genetic Counsellor and Manager at Guy's Hospital....
6 July 2009 - by Dr Will Fletcher 
A one-step gene mapping test for identifying genetic and chromosomal abnormalities in embryos may be available in the UK within a year. The technique, known as karyomapping, can screen for almost any inherited disease and is much faster than those currently available as it does not need prior knowledge of the specific gene mutation involved. The method was unveiled last week at the annual conference of the European Society for Human Reproduction and Embryology (ESHRE), in Amsterdam, after res...
27 October 2008 - by Dr Rebecca Robey 
UK scientists have developed a new screening technique that could allow prospective parents to test their IVF embryos for any known genetic disease. The test, dubbed 'a genetic MoT', would cost just £1500 and could be available by next year pending licensing by the Human Fertilisation and...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.